Total Payments
$7,814
2024 Payments
$1,056
Companies
36
Transactions
510
Medicare Patients
26,026
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$7,760 (99.3%)
Education$54.45 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,760 | 505 | 99.3% |
| Education | $54.45 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,288 | 92 | $0 (2024) |
| Amgen Inc. | $974.89 | 63 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $797.68 | 77 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $647.81 | 40 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $523.96 | 25 | $0 (2024) |
| PFIZER INC. | $443.01 | 51 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $432.78 | 23 | $0 (2022) |
| iRhythm Technologies, Inc. | $417.20 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $282.10 | 19 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $253.09 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,056 | 54 | iRhythm Technologies, Inc. ($213.66) |
| 2023 | $1,023 | 50 | Novartis Pharmaceuticals Corporation ($189.79) |
| 2022 | $707.38 | 43 | Novartis Pharmaceuticals Corporation ($173.85) |
| 2021 | $397.14 | 19 | AstraZeneca Pharmaceuticals LP ($164.39) |
| 2020 | $208.02 | 13 | Boehringer Ingelheim Pharmaceuticals, Inc. ($49.24) |
| 2019 | $1,430 | 108 | Amgen Inc. ($330.97) |
| 2018 | $1,486 | 108 | Janssen Pharmaceuticals, Inc ($344.90) |
| 2017 | $1,507 | 115 | Amgen Inc. ($335.04) |
All Payment Transactions
510 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.12 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/12/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $138.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $81.33 | General |
| Category: Pacemakers | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/01/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $74.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.29 | General |
| Category: Cardiovascular | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/03/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Not Applicable | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/27/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.47 | General |
| 07/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 6,164 | 9,845 | $1.3M | $462,881 |
| 2022 | 42 | 6,309 | 8,335 | $1.3M | $467,085 |
| 2021 | 44 | 6,805 | 9,738 | $1.6M | $588,145 |
| 2020 | 45 | 6,748 | 9,109 | $1.4M | $486,049 |
Total Patients
26,026
Total Services
37,027
Medicare Billing
$2.0M
Procedure Codes
175
All Medicare Procedures & Services
175 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,440 | 2,320 | $480,252 | $196,610 | 40.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 313 | 652 | $92,205 | $39,952 | 43.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 228 | 264 | $93,351 | $34,830 | 37.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 661 | 668 | $92,154 | $33,993 | 36.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 201 | 235 | $65,579 | $29,587 | 45.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 136 | 177 | $35,463 | $16,100 | 45.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 193 | 226 | $31,414 | $12,875 | 41.0% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 106 | 1,455 | $36,375 | $12,165 | 33.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 80 | 80 | $32,160 | $11,199 | 34.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 163 | 163 | $24,939 | $8,842 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $22,260 | $7,702 | 34.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 842 | 1,168 | $143,122 | $6,925 | 4.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 27 | 27 | $18,117 | $5,977 | 33.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 468 | 520 | $21,840 | $5,288 | 24.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 42 | $10,782 | $4,235 | 39.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 18 | $6,066 | $3,885 | 64.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 247 | 247 | $12,896 | $3,841 | 29.8% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 30 | 196 | $11,368 | $3,623 | 31.9% |
| 93798 | Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | Facility | 2023 | 16 | 330 | $9,900 | $3,405 | 34.4% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 31 | 33 | $17,522 | $2,686 | 15.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 33 | 33 | $7,458 | $2,600 | 34.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 243 | 243 | $8,775 | $2,552 | 29.1% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Facility | 2023 | 106 | 144 | $11,808 | $2,025 | 17.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 20 | $3,500 | $1,780 | 50.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 24 | 37 | $2,960 | $1,424 | 48.1% |
About Dr. Said Iskandar, MD
Dr. Said Iskandar, MD is a Cardiovascular Disease healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679608053.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Said Iskandar, MD has received a total of $7,814 in payments from pharmaceutical and medical device companies, with $1,056 received in 2024. These payments were reported across 510 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,760).
As a Medicare-enrolled provider, Iskandar has provided services to 26,026 Medicare beneficiaries, totaling 37,027 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 175 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Internal Medicine, Cardiovascular Disease
- Location Norfolk, VA
- Active Since 02/23/2007
- Last Updated 11/07/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1679608053
Products in Payments
- ENTRESTO (Drug) $1,039
- XARELTO (Drug) $797.68
- Corlanor (Drug) $548.04
- ELIQUIS (Drug) $535.43
- Repatha (Biological) $416.85
- JARDIANCE (Drug) $375.09
- BRILINTA (Drug) $364.80
- ZIO XT Patch (Device) $330.76
- PRADAXA (Drug) $272.72
- MULTAQ (Drug) $265.73
- LifeVest (Device) $253.09
- LEQVIO (Drug) $249.53
- VERQUVO (Drug) $193.79
- PRALUENT (Drug) $167.05
- PRALUENT ALIROCUMAB INJECTION (Biological) $156.99
- Kerendia (Drug) $151.82
- FARXIGA (Drug) $145.35
- CAMZYOS (Drug) $122.60
- HeartMate (Device) $84.93
- AZURE XT DR MRI SURESCAN (Device) $81.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Norfolk
Raymond Benza, Md, MD
Cardiovascular Disease — Payments: $193,679
Cardiovascular Disease $193,679
Dr. Matthew Summers, M.d, M.D
Cardiovascular Disease — Payments: $156,914
Cardiovascular Disease $156,914
Dr. Zackary Tushak, D.o, D.O
Cardiovascular Disease — Payments: $49,619
Cardiovascular Disease $49,619
Kunal Kapoor
Cardiovascular Disease — Payments: $27,329
Cardiovascular Disease $27,329
Saumil Patel, M.d, M.D
Cardiovascular Disease — Payments: $10,301
Cardiovascular Disease $10,301
William Callaghan, M.d, M.D
Cardiovascular Disease — Payments: $9,593
Cardiovascular Disease $9,593